Quantum dot-enhanced tunable FRET nanosensor for Alzheimer's-associated dual miR-34 detection.

Area of Science:

• Biomolecular Engineering
• Nanotechnology
• Diagnostic Assay Development

Background:

• MicroRNAs miR-34a and miR-34b are implicated in Alzheimer's disease (AD) pathogenesis.
• Their low abundance, sequence homology, and instability hinder accurate multiplex detection for AD diagnosis.

Purpose of the Study:

• To develop a sensitive and specific platform for simultaneous detection of homologous microRNAs miR-34a and miR-34b.
• To overcome challenges in multiplex miRNA detection for improved Alzheimer's disease diagnostics.

Main Methods:

• A quantum dot-enhanced turn-up/down dual-miRNA Förster Resonance Energy Transfer (FRET) sensor (QDTF sensor) was designed.
• An asymmetric dual-mode FRET strategy utilizing a single quantum dot 605 and spectrally distinct dye pairs was employed.
• The sensor was tested directly in artificial cerebrospinal fluid (aCSF) without amplification or pretreatment.

Main Results:

• The QDTF sensor achieved simultaneous detection of miR-34a and miR-34b with low crosstalk (<3.42%).
• Ultrasensitive detection limits were achieved: 0.96 pM for miR-34a and 1.12 pM for miR-34b.
• A significant sensitivity enhancement (322-fold for miR-34a, 203-fold for miR-34b) compared to dye-only beacons was demonstrated.

Conclusions:

• The QDTF sensor provides a robust and precise method for quantifying homologous miRNAs in undiluted aCSF.
• This platform holds significant potential for the early clinical diagnosis of Alzheimer's disease.